Delivery Order SPE2DB22D1106-SPE2DB25FFFD2
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a $1,530.00 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Fulvestrant 250 mg/5 mL syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single delivery order fulfillment under AmerisourceBergen's larger indefinite delivery contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Fulvestrant 250 mg/5 mL syringes (5 mL quantity) with a contract ceiling value of $1,224.00. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and was awarded competitively without set-aside restrictions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fulvestrant 250 mg/5 mL syringes with a ceiling value of $1,145.70. This non-set-aside, competitively awarded delivery order features firm fixed pricing and is scheduled for completion by August 8, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fulvestrant 250 mg/5 ml syringes, a specialty medication, under a delivery order valued at $1,231.10. The contract has an ultimate completion date of December 27, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency Troop Support Medical awarded a $573,700 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the provision of 4561376311 Fulvestrant 250 mg/5 ml syringes. The contract calls for Amerisourcebergen to deliver 5 ml syringes of the breast cancer drug Fulvestrant to the agency. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from June 29, 2023 to June 30, 2023. No subcontractors...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,565,754,275 units of Fulvestrant 250 mg/5 ml syringe medication. The firm-fixed-price contract is valued at $1,603.60 and has a period of performance through September 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by DLA Troop Support Medical and other...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Fulvestrant 250 mg/5 ml syringes, with a ceiling value of $1,833.12 and a period of performance through May 8, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,060.00 firm-fixed-price contract is for the supply of 4567008677 - Fulvestrant 250 mg/5 ml syringes. The contract has a completion date of January 23, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,145.70, is for the supply of 4567954913 FULVESTRANT 250 MG/5 ML SYRING 5ML, a pharmaceutical product, with a period of performance through April 18, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,097.53 firm-fixed price delivery order is for the supply of 4566293391 FULVESTRANT 250 MG/5 ML SYRING 5ML, a specialty pharmaceutical product, with an ultimate completion date of November 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFFD2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,083.35 to AmerisourceBergen Drug Corp for Fulvestrant 250 mg/5 ml syringes on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement needs through its extensive contract portfolio with DLA and other government healthcare systems. The Fulvestrant delivery represents one of numerous pharmaceutical deliveries the company provides to support military and veteran healthcare, including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. As a critical vendor in the federal medical supply chain, AmerisourceBergen has demonstrated capability to meet competitive federal procurement requirements through its consistent award history and versatile fulfillment of healthcare commodities ranging from low-value transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 8/25/25 |